Genmab A/S/ DK0010272202 /
03/06/2024 14:46:52 | Chg. - | Volume | Bid16:21:37 | Ask16:55:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,954.25DKK | - | 20 Turnover: 39,085 |
-Bid Size: - | -Ask Size: - | 128.02 bill.DKK | - | 29.07 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 66.64 DKK | -20.08% |
EPS Diluted: | - DKK | -20.06% |
Revenues per Share: | 249.32 DKK | 12.37% |
Book Value per Share: | 478.40 DKK | 14.63% |
Cash Flow per Share: | 111.69 DKK | 86.64% |
Dividend per Share: | - DKK | - |
Total | in mill. | |
Revenues: | 16,474.00 DKK | 13.57% |
Net Income: | 4,352.00 DKK | -20.18% |
Operating Cash Flow: | 7,380.00 DKK | - |
Cash and Cash Equivalents: | 14,867.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 29.07 | 32.34 |
P/S Ratio: | 7.77 | 8.64 |
P/BV ratio: | 4.05 | 4.50 |
P/CF Ratio: | 17.35 | 19.29 |
PEG: | -1.45 | -1.61 |
Earnings Yield: | 3.44% | 3.09% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 128.02 bill. DKK | 142.39 bill. DKK |
Free Float Market Cap.: | - DKK | - DKK |
Market Cap. / Employee: | 58.09 mill. DKK | 64.61 mill. DKK |
Shares Outstanding: | 66.07 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | 32.30% |
Net Profit Margin: | 26.42% |
Return on Equity: | 13.77% |
Return on Assets: | 12.33% |
Financial Strength
Liquidity I / Cash Ratio: | 598.51% |
Liquidity II / Quick Ratio: | 800.16% |
Liquidity III / Current Ratio: | 1,334.10% |
Debt / Equity Ratio: | 11.64% |
Dynam. Debt / Equity Ratio: | 49.85% |
Efficiency
Employees: | 2,204 |
Personal Expenses / Employee: | - DKK |
Revenues / Employee: | 7,474,591.65 DKK |
Net Income / Employee: | 1,974,591.65 DKK |
Total Assets / Employee: | 16,011,343.01 DKK |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | IFRS |
Currency: | DKK |